The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumors with high dose chemotherapy as consolidation- a non-cisplatin- based induction approach.

Title:	The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumors with high dose chemotherapy as consolidation- a non-cisplatin- based induction approach.
Authors:	Badreldin, W Krell, J Chowdhury, S Harland, S Mazhar, D Harding, V Frampton, A Wilson, P Berney, D Stebbing, J Shamash, J
Item Type:	Journal Article
Issue Date:	28-Nov-2014
Date of Acceptance:	21-Nov-2014
URI:	http://hdl.handle.net/10044/1/21700
DOI:	https://dx.doi.org/10.1111/bju.13004
ISSN:	1464-4096
Publisher:	Wiley
Start Page:	418
End Page:	423
Journal / Book Title:	BJU International
Volume:	117
Issue:	3
Copyright Statement:	© 2015 Wiley. This is the peer reviewed version of the following article: The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumors with high dose chemotherapy as consolidation- a non-cisplatin- based induction approach, BJU International, 2015, which has been published in final form at https://dx.doi.org/10.1111/bju.13004. This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.
Sponsor/Funder:	National Institute for Health Research Cancer Research UK
Funder's Grant Number:	NIHR-RP-011-053 C27532/A14549
Keywords:	cisplatin resistance germ cell tumours relapse germ cell tumors Urology & Nephrology 1103 Clinical Sciences
Publication Status:	Published
Appears in Collections:	Department of Surgery and Cancer